Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2021;71:209–49.

Google Scholar 

McBride AA. Oncogenic human papillomaviruses. Philos Trans R Soc B: Biol Sci. 2017;372:20160273.

Article  Google Scholar 

Scarth JA, Patterson MR, Morgan EL, Macdonald A. The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation. J Gen Virol. 2021;102:001540.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wetherill LF, Holmes KK, Verow M, Müller M, Howell G, Harris M, et al. High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors. J Virol. 2012;86:5341–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mller M, Prescott EL, Wasson CW, Macdonald A. Human papillomavirus E5 oncoprotein: function and potential target for antiviral therapeutics. Future Virol. 2015;10:27–39.

Article  Google Scholar 

Wasson CW, Morgan EL, Müller M, Ross RL, Hartley M, Roberts S, et al. Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle. Oncotarget. 2017;8:103581–600.

Article  PubMed  PubMed Central  Google Scholar 

Wetherill LF, Wasson CW, Swinscoe G, Kealy D, Foster R, Griffin S, et al. Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5. Antivir Res. 2018;158:113–21.

Article  CAS  PubMed  Google Scholar 

Münger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 1989;8:4099–105.

Article  PubMed  PubMed Central  Google Scholar 

Dyson N, Howley PM, Münger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934–7.

Article  CAS  PubMed  Google Scholar 

Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993;75:495–505.

Article  CAS  PubMed  Google Scholar 

Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996;56:4620–4.

CAS  PubMed  Google Scholar 

Spangle JM, Münger K The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species. Roman A, editor. PLoS Pathogens. 2013;9:e1003237.

He C, Mao D, Hua G, Lv X, Chen X, Angeletti PC, et al. The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression. EMBO Mol Med. 2015;7:1426–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soto DR, Barton C, Munger K, McLaughlin-Drubin ME. KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress. PLoS Pathog. 2017;13:e1006661.

Article  PubMed  PubMed Central  Google Scholar 

Sitz J, Blanchet SA, Gameiro SF, Biquand E, Morgan TM, Galloy M, et al. Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response. Proc Natl Acad Sci. 2019;116:19552–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morgan EL, Patterson MR, Ryder EL, Lee SY, Wasson CW, Harper KL, et al. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer. Kalejta RF, editor. PLoS Pathogens. 2020;16:e1008624.

Morgan EL, Patterson MR, Barba-Moreno D, Scarth JA, Wilson A, Macdonald A. The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer. Oncogene. 2021;40:2112–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morgan EL, Scarth JA, Patterson MR, Wasson CW, Hemingway GC, Barba-Moreno D, et al. E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer. Cell Death Differ. 2021;28:1669–87.

Article  CAS  PubMed  Google Scholar 

Scarth JA, Wasson CW, Patterson MR, Evans D, Barba-Moreno D, Carden H, et al. Exploitation of ATP-sensitive potassium ion (KATP) channels by HPV promotes cervical cancer cell proliferation by contributing to MAPK/AP-1 signalling. Oncogene. 2023;42:2558–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tomasetto C, Moog-Lutz C, Régnier CH, Schreiber V, Basset P, Rio MC. Lasp‐1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains. FEBS Lett. 1995;373:245–9.

Article  CAS  PubMed  Google Scholar 

Butt E, Raman D. New frontiers for the cytoskeletal protein LASP1. Front Oncol. 2018;8:391.

Article  PubMed  PubMed Central  Google Scholar 

Niu Y, Shao Z, Wang H, Yang J, Zhang F, Luo Y, et al. LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling. Sci Rep. 2016;6:26112.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao Q, Tang L, Wu L, Li K, Wang H, Li W, et al. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN. Cell Death Dis. 2018;9:393.

Article  PubMed  PubMed Central  Google Scholar 

Hailer A, Grunewald TG, Orth M, Reiss C, Kneitz B, Spahn M, et al. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration. Oncotarget. 2014;5:4144–53.

Article  PubMed  PubMed Central  Google Scholar 

Wang W, Ji G, Xiao X, Chen X, Qin WW, Yang F, et al. Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1. Oncotarget. 2016;7:68674–87.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X, Liu Y, Fan C, Wang L, Li A, Zhou H, et al. Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway. Oncotarget. 2017;8:75102–13.

Article  PubMed  PubMed Central  Google Scholar 

Howard CM, Bearss N, Subramaniyan B, Tilley A, Sridharan S, Villa N, et al. The CXCR4-LASP1-eIF4F axis promotes translation of oncogenic proteins in triple-negative breast cancer cells. Front Oncol. 2019;9:284.

Article  PubMed  PubMed Central  Google Scholar 

Butt E, Stempfle K, Lister L, Wolf F, Kraft M, Herrmann AB, et al. Phosphorylation-dependent differences in CXCR4-LASP1-AKT1 Interaction between Breast Cancer and Chronic Myeloid Leukemia. Cells. 2020;9:444.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Subramaniyan, Sridharan B, Howard S, Tilley CM, Basuroy AMC, Serna T, et al. Role of the CXCR4-LASP1 axis in the stabilization of Snail1 in triple-negative breast cancer. Cancers. 2020;12:2372.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi JW, Kim JW, Nguyen LP, Nguyen HC, Park EM, Choi DH, et al. Nonstructural NS5A protein regulates LIM and SH3 domain protein 1 to promote hepatitis C virus propagation. Mol Cells. 2020;43:469–78.

CAS  PubMed  PubMed Central  Google Scholar 

You H, Yuan D, Bi Y, Zhang N, Li Q, Tu T, et al. Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis. Cell Commun Signal. 2021;19:33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL, et al. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res. 2007;67:10163–72.

Article  CAS  PubMed  Google Scholar 

Pyeon, Newton D, Lambert MA, Boon PF, den JA, Sengupta S, et al. Fundamental differences in cell cycle deregulation in human papillomavirus–positive and human papillomavirus–negative head/neck and cervical cancers. Cancer Res. 2007;67:4605–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer. 2008;47:755–65.

Article  CAS  PubMed  Google Scholar 

Boon, den JA, Pyeon D, Wang SS, Horswill M, Schiffman M, et al. Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proc Natl Acad Sci USA. 2015;112:E3255–64. Jun 23

Google Scholar 

James CD, Das D, Morgan EL, Otoa R, Macdonald A, Morgan IM. Werner syndrome protein (WRN) regulates cell proliferation and the human papillomavirus 16 life cycle during epithelial differentiation. mSphere. 2020;5:e00858–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Müller M, Wasson CW, Bhatia R, Boxall S, Millan D, Goh GYS, et al. YIP1 family member 4 (YIPF4) is a novel cellular binding partner of the papillomavirus E5 proteins. Sci Rep. 2015;5:12523.

Article